Daliani D - Search Results

1

Development of angiogenesis inhibition as therapy for prostate cancer.

Daliani D. Daliani D. Oncology (Williston Park). 2000 Dec;14(12 Suppl 13):21-3. Oncology (Williston Park). 2000. PMID: 11204669 Review.

2

The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancer.

Daliani DD, Eisenberg PD, Weems J, Lord R, Fueger R, Logothetis CJ. Daliani DD, et al. J Urol. 1995 May;153(5):1587-91. J Urol. 1995. PMID: 7536271 Clinical Trial.

3

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial.

Tu SM, Millikan RE, Mengistu B, Delpassand ES, Amato RJ, Pagliaro LC, Daliani D, Papandreou CN, Smith TL, Kim J, Podoloff DA, Logothetis CJ. Tu SM, et al. Among authors: daliani d. Lancet. 2001 Feb 3;357(9253):336-41. doi: 10.1016/S0140-6736(00)03639-4. Lancet. 2001. PMID: 11210994 Clinical Trial.

4

Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer.

Logothetis CJ, Wu KK, Finn LD, Daliani D, Figg W, Ghaddar H, Gutterman JU. Logothetis CJ, et al. Among authors: daliani d. Clin Cancer Res. 2001 May;7(5):1198-203. Clin Cancer Res. 2001. PMID: 11350884 Clinical Trial.

5

Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma.

Pagliaro LC, Millikan RE, Tu SM, Williams D, Daliani D, Papandreou CN, Logothetis CJ. Pagliaro LC, et al. Among authors: daliani d. J Clin Oncol. 2002 Jul 1;20(13):2965-70. doi: 10.1200/JCO.2002.11.114. J Clin Oncol. 2002. PMID: 12089226 Clinical Trial.

6

Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate.

Papandreou CN, Daliani DD, Thall PF, Tu SM, Wang X, Reyes A, Troncoso P, Logothetis CJ. Papandreou CN, et al. Among authors: daliani dd. J Clin Oncol. 2002 Jul 15;20(14):3072-80. doi: 10.1200/JCO.2002.12.065. J Clin Oncol. 2002. PMID: 12118020 Clinical Trial.

7

A pilot study of thalidomide in patients with progressive metastatic renal cell carcinoma.

Daliani DD, Papandreou CN, Thall PF, Wang X, Perez C, Oliva R, Pagliaro L, Amato R. Daliani DD, et al. Cancer. 2002 Aug 15;95(4):758-65. doi: 10.1002/cncr.10740. Cancer. 2002. PMID: 12209719 Free article. Clinical Trial.

8

Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinoma.

Daliani DD, Assikis V, Tu SM, Papandreou CN, Pagliaro LC, Holtkamp T, Wang X, Thall PF, Logothetis CJ. Daliani DD, et al. Cancer. 2003 Feb 1;97(3):561-7. doi: 10.1002/cncr.11078. Cancer. 2003. PMID: 12548597 Free article. Clinical Trial.

9

Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience.

Siefker-Radtke AO, Gee J, Shen Y, Wen S, Daliani D, Millikan RE, Pisters LL. Siefker-Radtke AO, et al. Among authors: daliani d. J Urol. 2003 Apr;169(4):1295-8. doi: 10.1097/01.ju.0000054646.49381.01. J Urol. 2003. PMID: 12629346

10

Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer.

Papandreou CN, Daliani DD, Nix D, Yang H, Madden T, Wang X, Pien CS, Millikan RE, Tu SM, Pagliaro L, Kim J, Adams J, Elliott P, Esseltine D, Petrusich A, Dieringer P, Perez C, Logothetis CJ. Papandreou CN, et al. Among authors: daliani dd. J Clin Oncol. 2004 Jun 1;22(11):2108-21. doi: 10.1200/JCO.2004.02.106. J Clin Oncol. 2004. PMID: 15169797 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters